All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

Ebola (EBOV): caratteristiche, trasmissione, sintomi e trattamento della febbre emorragica

By

Francesco Redi

3d ago· 2 min readitInsight

Summary

Il virus Ebola (EBOV), scoperto nel 1976 nella Repubblica Democratica del Congo, è un patogeno della famiglia Filoviridae che causa la Malattia da Virus Ebola (MVE), una febbre emorragica con mortalità fino al 90% nei casi non trattati. L'articolo descrive le caratteristiche del virus, la sua trasmissione, i sintomi e le opzioni terapeutiche, offrendo una guida informativa su uno dei patogeni più pericolosi al mondo.

Key quotes

· 4 pulled
Il virus Ebola (EBOV) è uno dei patogeni più pericolosi e drammaticamente efficaci mai identificati.
Isolato per la prima volta nel 1976 nei pressi del fiume Ebola, nella Repubblica Democratica del Congo, appartiene alla famiglia Filoviridae.
Causa la Malattia da Virus Ebola (MVE), una febbre emorragica ad altissima mortalità che può raggiungere il 90% dei casi non trattati.
Nonostante la sua notorietà mediatica, molti aspetti clinici e laboratoristici restano poco conosciuti al grande pubblico.
Snippet from the RSS feed
Cos'è il virus Ebola, come si trasmette, quali sintomi provoca e come si cura. La guida alla malattia per uno dei patogeni più pericolosi.

You might also wanna read

Exploring the science behind quantum effects in healthcare: separating research from pseudoscience

The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg

newscientist.com·1h ago

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug

chicagotribune.com·1h ago

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug

chicagotribune.com·1h ago

Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds

An experimental pill called daraxonrasib has shown promise in helping patients with advanced pancreatic cancer live longer. The drug blocks

bit.ly·4h ago

Woman develops whiplike rash on back after eating shiitake mushrooms

A woman developed bright-red, whiplike rashes on her back after eating shiitake mushrooms, a condition known as shiitake dermatitis. The cas

livescience.com·5h ago

Molecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial

Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins

pasadenastarnews.com·8h ago